PTAB challenges

Based on a review of the USPTO's Patent Trial and Appeal Board (PTAB) records, there have been no inter partes review (IPR), post-grant review (PGR), or covered business method (CBM) proceedings filed against U.S. Patent No. 11,120,271. This provides a clear defensive landscape, as the patent's validity has not yet been challenged at the PTAB.

Proceedings Overview

There are no PTAB proceedings on file for U.S. Patent No. 11,120,271. Consequently, all claims remain as originally granted, and a defendant would be the first to challenge the patent's validity before the PTAB.

---

Strategic Summary

All claims of U.S. Patent 11,120,271 are currently valid and untested in any AIA trial proceeding. No claims have been canceled, and none have been sustained against a validity challenge at the PTAB.

The estoppel landscape is entirely open. Since no IPR or PGR has been instituted against this patent, the estoppel provisions of 35 U.S.C. § 315(e) do not apply to any potential petitioner. A defendant would be free to raise any prior art-based invalidity ground in a future PTAB proceeding without restriction from a prior challenge.

The absence of any PTAB challenges to date is notable. While not definitive, it can suggest that the patent has not been widely asserted in litigation, as patents involved in active licensing or enforcement campaigns often attract IPRs from accused infringers or defensive aggregators.

Recommended Next Steps

For a company facing an assertion of U.S. Patent No. 11,120,271, the path is clear for a potential validity challenge at the PTAB.

• No PTAB History: There are no prior PTAB proceedings to analyze. A defendant would be starting with a clean slate, able to construct a validity challenge without being constrained by any prior arguments or estoppels. This provides maximum flexibility in developing a defensive strategy, including conducting a thorough prior art search to identify the strongest grounds for an IPR petition.